Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19
NCT ID: NCT06318208
Last Updated: 2024-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
110 participants
OBSERVATIONAL
2021-04-20
2022-01-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, 110 patients, aged 6-60 years, were recruited by telephone 4-12 weeks after laboratory-confirmed positive PCR and invited for a lung function testing. Every patient with abnormalities in pulmonary function was invited to a follow-up 3 months after the first appointment to assess changes in lung function values.
Patients with a pre-existing lung disease and smokers within the last five years were excluded beforehand.
Additionally to lung function testing we did a throat swab at each appointment to analyse via Multiplex PCR whether the patients had any other respiratory infection at the time of the pulmonary function testing.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Late Respiratory Consequences of SARS-CoV-2 Pneumonia
NCT05812196
Persistent Dyspnea in Post COVID_19 and Pulmonary Function
NCT05228678
Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19
NCT04535154
Impact of COVID-19 on Lung Function in COPD Patients.
NCT05770440
Long Term Outcomes of Coronavirus Disease-19 (COVID-19)
NCT04715919
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lung function testing
lung function testing including LCI, FEV1, FVC, DLCO
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rostock
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexandra Rachel Görges
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manfred Ballmann, Prof. Dr.
Role: STUDY_DIRECTOR
UMR Kinder- und Jugendklinik
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kinder- und Jugendklinik Universitätsmedizin Rostock
Rostock, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-LCI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.